Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Neuroscience

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    October 2018
  1. LIU Y, Wei M, Yue K, Hu M, et al
    Study on urine metabolic profile of Abeta25-35-induced Alzheimer's disease by using UHPLC-Q-TOF-MS.
    Neuroscience. 2018 Oct 11. pii: S0306-4522(18)30662.
    PubMed     Text format     Abstract available


    September 2018
  2. PU Z, Ma S, Wang L, Li M, et al
    Amyloid-beta Degradation and Neuroprotection of Dauricine Mediated by Unfolded Protein Response in a Caenorhabditis elegans model of Alzheimer's disease.
    Neuroscience. 2018 Sep 26. pii: S0306-4522(18)30620.
    PubMed     Text format     Abstract available


  3. LIU JY, Chen XX, Chen HY, Shi J, et al
    Downregulation of aquaporin 9 exacerbates beta-amyloid-induced neurotoxicity in Alzheimer's disease models in vitro and in vivo.
    Neuroscience. 2018 Sep 25. pii: S0306-4522(18)30614.
    PubMed     Text format     Abstract available


    June 2018
  4. GROLEAU M, Chamoun M, Vaucher E
    Stimulation of acetylcholine release and pharmacological potentiation of cholinergic transmission affect cholinergic receptor expression differently during visual conditioning.
    Neuroscience. 2018 Jun 26. pii: S0306-4522(18)30434.
    PubMed     Text format     Abstract available


  5. HUANG J, Chen S, Hu L, Niu H, et al
    Mitoferrin-1 is Involved in the Progression of Alzheimer's Disease Through Targeting Mitochondrial Iron Metabolism in a Caenorhabditis elegans Model of Alzheimer's Disease.
    Neuroscience. 2018 Jun 13. pii: S0306-4522(18)30422.
    PubMed     Text format     Abstract available


    May 2018
  6. LI J, Rao D, Gibbs RB
    Effects of Cholinergic Lesions and Cholinesterase Inhibitors on Aromatase and Estrogen Receptor Expression in Different Regions of the Rat Brain.
    Neuroscience. 2018 May 28. pii: S0306-4522(18)30383.
    PubMed     Text format     Abstract available


  7. CHOI S, Won JS, Carroll SL, Annamalai B, et al
    Pathology of nNOS expressing GABAergic neurons in mouse model of Alzheimer's disease.
    Neuroscience. 2018 May 18. pii: S0306-4522(18)30356.
    PubMed     Text format     Abstract available


    March 2018
  8. IZUMI H, Shinoda Y, Saito T, Saido T, et al
    The disease-modifying drug candidate, SAK3 improves cognitive impairment and inhibits amyloid beta deposition in App knock-in mice.
    Neuroscience. 2018 Mar 3. pii: S0306-4522(18)30156.
    PubMed     Text format     Abstract available


    February 2018
  9. MURRAY HC, Swanson MEV, Dieriks BV, Turner C, et al
    Neurochemical Characterization of PSA-NCAM(+) Cells in the Human Brain and Phenotypic Quantification in Alzheimer's Disease Entorhinal Cortex.
    Neuroscience. 2018;372:289-303.
    PubMed     Text format     Abstract available


  10. DE LIMA OLIVEIRA BC, Bellozi PMQ, Reis HJ, de Oliveira ACP, et al
    Inflammation as a possible link between dyslipidemia and Alzheimer's disease.
    Neuroscience. 2018 Feb 14. pii: S0306-4522(18)30127.
    PubMed     Text format     Abstract available


  11. SIMON E, Obst J, Gomez-Nicola D
    The evolving dialogue of microglia and neurons in Alzheimer's disease: microglia as necessary transducers of pathology.
    Neuroscience. 2018 Feb 7. pii: S0306-4522(18)30089.
    PubMed     Text format     Abstract available


    January 2018
  12. NACHER J
    Plasticity Molecule Reveals Interneuronal Alterations in Alzheimer's Disease.
    Neuroscience. 2018 Jan 17. pii: S0306-4522(18)30028.
    PubMed     Text format    


  13. OMTRI RS, Thompson K, Tang X, Gali CC, et al
    Differential Effects of Alzheimer's Disease Abeta40 and 42 on Endocytosis and Intraneuronal Trafficking.
    Neuroscience. 2018 Jan 11. pii: S0306-4522(18)30019.
    PubMed     Text format     Abstract available


  14. NYARKO JNK, Quartey MO, Pennington PR, Heistad RM, et al
    Profiles of beta-amyloid peptides and key secretases in brain autopsy samples differ with sex and APOE epsilon4 status: impact for risk and progression of Alzheimer disease.
    Neuroscience. 2018 Jan 10. pii: S0306-4522(18)30021.
    PubMed     Text format     Abstract available


    November 2017
  15. MASCALI D, DiNuzzo M, Serra L, Mangia S, et al
    Disruption of Semantic Network in Mild Alzheimer's Disease Revealed by Resting-State fMRI.
    Neuroscience. 2017 Nov 29. pii: S0306-4522(17)30824.
    PubMed     Text format     Abstract available


    October 2017
  16. LI J, Gong Y, Tang X
    Hierarchical subcortical sub-regional shape network analysis in Alzheimer's disease.
    Neuroscience. 2017 Oct 13. pii: S0306-4522(17)30730.
    PubMed     Text format     Abstract available


    August 2017
  17. DJORDJEVIC J, Thomson E, Chowdhury SR, Snow WM, et al
    Brain region- and sex-specific alterations in mitochondrial function and NF-kappaB signaling in the TgCRND8 mouse model of Alzheimer's disease.
    Neuroscience. 2017 Aug 9. pii: S0306-4522(17)30564.
    PubMed     Text format     Abstract available


    July 2017
  18. EL KADMIRI N, Said N, Slassi I, El Moutawakil B, et al
    Biomarkers for Alzheimer disease: Classical and novel candidates' review.
    Neuroscience. 2017 Jul 17. pii: S0306-4522(17)30487.
    PubMed     Text format     Abstract available


    June 2017
  19. KORABECNY J, Nepovimova E, Cikankova T, Spilovska K, et al
    Newly developed drugs for Alzheimer's disease in relation to energy metabolism, cholinergic and monoaminergic neurotransmission.
    Neuroscience. 2017 Jun 30. pii: S0306-4522(17)30439.
    PubMed     Text format     Abstract available


    May 2017
  20. QIU WQ
    Amylin and its G-protein-coupled receptor: a probable pathological process and drug target for Alzheimer's disease.
    Neuroscience. 2017 May 18. pii: S0306-4522(17)30349.
    PubMed     Text format     Abstract available


    April 2017
  21. OLIVEIRA-SOUZA FG, DeRamus ML, van Groen T, Lambert AE, et al
    Retinal changes in the Tg-SwDI mouse model of Alzheimer's disease.
    Neuroscience. 2017 Apr 25. pii: S0306-4522(17)30270.
    PubMed     Text format     Abstract available


  22. ESTEVES IM, Lopes-Aguiar C, Rossignoli MT, Ruggiero RN, et al
    Chronic nicotine attenuates behavioral and synaptic plasticity impairments in a streptozotocin model of Alzheimer's disease.
    Neuroscience. 2017 Apr 19. pii: S0306-4522(17)30258.
    PubMed     Text format     Abstract available


  23. FUHRER TE, Palpagama TH, Waldvogel HJ, Synek BJ, et al
    Impaired expression of GABA transporters in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.
    Neuroscience. 2017 Apr 3. pii: S0306-4522(17)30207.
    PubMed     Text format     Abstract available


    January 2017
  24. CHEN JL, Zhang DL, Sun Y, Zhao YX, et al
    Angiotensin-(1-7) administration attenuates Alzheimer's disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation.
    Neuroscience. 2017 Jan 29. pii: S0306-4522(17)30040.
    PubMed     Text format     Abstract available


    March 2016
  25. VECCHIO F, Miraglia F, Quaranta D, Granata G, et al
    Cortical connectivity and memory performance in cognitive decline: A study via graph theory from EEG data.
    Neuroscience. 2016;316:143-50.
    PubMed     Text format     Abstract available


    January 2016
  26. SARLAK G, Htoo HH, Hernandez JF, Iizasa H, et al
    Sox2 functionally interacts with betaAPP, the betaAPP intracellular domain and ADAM10 at a transcriptional level in human cells.
    Neuroscience. 2016;312:153-64.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: